Lupin Limited
LUPIN
Rankning i aktier
#2104
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Aktiekurs
$21.43
Marknadsvärde
$9.80B
Förändring (1 dag)
0.14%
Förändring (1 år)
-2.88%
Land
IN
Handel Lupin Limited (LUPIN)
Kategori
Healthcare
Antal utestående aktier för Lupin Limited (LUPIN)
Antal utestående aktier per June 2026: 457.19M
Enligt de senaste finansiella rapporterna och aktiekursen för Lupin Limited är det aktuella antalet utestående aktier 457.19M. I slutet av March 2024 hade företaget 457.24M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Lupin Limited (LUPIN) från 2004 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 457.19M | -0.12% |
| 2025 | 457.75M | 0.11% |
| 2024 | 457.24M | 0.04% |
| 2023 | 457.05M | 0.66% |
| 2022 | 454.04M | -0.27% |
| 2021 | 455.29M | 0.57% |
| 2020 | 452.71M | 0.10% |
| 2019 | 452.25M | -0.29% |
| 2018 | 453.54M | 0.13% |
| 2017 | 452.97M | 0.10% |
| 2016 | 452.51M | 0.17% |
| 2015 | 451.74M | 0.00% |
| 2014 | 451.74M | 0.58% |
| 2013 | 449.13M | 0.60% |
| 2012 | 446.46M | 0.20% |
| 2011 | 445.58M | 3.52% |
| 2010 | 430.42M | 4.42% |
| 2009 | 412.21M | 0.99% |
| 2008 | 408.17M | 1.65% |
| 2007 | 401.54M | 0.03% |
| 2006 | 401.41M | 0.00% |
| 2005 | 401.41M | 0.00% |
| 2004 | 401.41M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 424.80% |
IN
|
